Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades
We aimed to assess SSc mortality by age in the general population over the past five decades. This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and...
Gespeichert in:
Veröffentlicht in: | Rheumatology (Oxford, England) England), 2024-02, Vol.63 (2), p.466-471 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 471 |
---|---|
container_issue | 2 |
container_start_page | 466 |
container_title | Rheumatology (Oxford, England) |
container_volume | 63 |
creator | Yen, Eric Y Singh, Devanshu R Singh, Ram Raj |
description | We aimed to assess SSc mortality by age in the general population over the past five decades.
This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters.
SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)].
Mortality for SSc has steadily decreased at younger ages over the past five decades. |
doi_str_mv | 10.1093/rheumatology/kead233 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10836968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2818055205</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</originalsourceid><addsrcrecordid>eNpVUU1v1DAQtRCIlsI_QMhHLkttT-K1TwhV5UOqxAE4m4k92TUk8WI7K-Xfk6rLqpzmjWbem4_H2Gsp3klh4TrvaR6xpiHtluvfhEEBPGGXstFqIwDU0zNWzQV7UcovIUQrwTxnF7BVUhtrLtnPb3WlLjyQz4SFeJx4WUqlMXpe_EA5lVj4mHLFIdaFZ6xUOFa-pHnaUea4W_N0XFHdEz9gqbyPR7pXxEDlJXvW41Do1SlesR8fb7_ffN7cff305ebD3caDVHVjpbRCd61FsjaADrRF33nTQ9MEo7cQNHjsCRrsFLUNmPUu01mt27DtvYUr9v5B9zB3IwVPU804uEOOI-bFJYzu_8oU926Xjk4KA9pqsyq8PSnk9GemUt0Yi6dhwInSXJwy0oi2VaJdW5uHVr--p2Tqz3OkcPfuuMfuuJM7K-3N4x3PpH92wF8LxJOJ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2818055205</pqid></control><display><type>article</type><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</creator><creatorcontrib>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</creatorcontrib><description>We aimed to assess SSc mortality by age in the general population over the past five decades.
This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters.
SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)].
Mortality for SSc has steadily decreased at younger ages over the past five decades.</description><identifier>ISSN: 1462-0324</identifier><identifier>ISSN: 1462-0332</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kead233</identifier><identifier>PMID: 37216898</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Clinical Science ; Databases, Factual ; Humans ; Mortality ; Risk Factors ; Scleroderma, Systemic</subject><ispartof>Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.466-471</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</cites><orcidid>0000-0002-6831-4538</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37216898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yen, Eric Y</creatorcontrib><creatorcontrib>Singh, Devanshu R</creatorcontrib><creatorcontrib>Singh, Ram Raj</creatorcontrib><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><description>We aimed to assess SSc mortality by age in the general population over the past five decades.
This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters.
SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)].
Mortality for SSc has steadily decreased at younger ages over the past five decades.</description><subject>Clinical Science</subject><subject>Databases, Factual</subject><subject>Humans</subject><subject>Mortality</subject><subject>Risk Factors</subject><subject>Scleroderma, Systemic</subject><issn>1462-0324</issn><issn>1462-0332</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1v1DAQtRCIlsI_QMhHLkttT-K1TwhV5UOqxAE4m4k92TUk8WI7K-Xfk6rLqpzmjWbem4_H2Gsp3klh4TrvaR6xpiHtluvfhEEBPGGXstFqIwDU0zNWzQV7UcovIUQrwTxnF7BVUhtrLtnPb3WlLjyQz4SFeJx4WUqlMXpe_EA5lVj4mHLFIdaFZ6xUOFa-pHnaUea4W_N0XFHdEz9gqbyPR7pXxEDlJXvW41Do1SlesR8fb7_ffN7cff305ebD3caDVHVjpbRCd61FsjaADrRF33nTQ9MEo7cQNHjsCRrsFLUNmPUu01mt27DtvYUr9v5B9zB3IwVPU804uEOOI-bFJYzu_8oU926Xjk4KA9pqsyq8PSnk9GemUt0Yi6dhwInSXJwy0oi2VaJdW5uHVr--p2Tqz3OkcPfuuMfuuJM7K-3N4x3PpH92wF8LxJOJ</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Yen, Eric Y</creator><creator>Singh, Devanshu R</creator><creator>Singh, Ram Raj</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6831-4538</orcidid></search><sort><creationdate>20240201</creationdate><title>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</title><author>Yen, Eric Y ; Singh, Devanshu R ; Singh, Ram Raj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-911906b59ae99d36de7acbc8f344d8673d63cafe34ab2e54380328b9665d7fc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Clinical Science</topic><topic>Databases, Factual</topic><topic>Humans</topic><topic>Mortality</topic><topic>Risk Factors</topic><topic>Scleroderma, Systemic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yen, Eric Y</creatorcontrib><creatorcontrib>Singh, Devanshu R</creatorcontrib><creatorcontrib>Singh, Ram Raj</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yen, Eric Y</au><au>Singh, Devanshu R</au><au>Singh, Ram Raj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>63</volume><issue>2</issue><spage>466</spage><epage>471</epage><pages>466-471</pages><issn>1462-0324</issn><issn>1462-0332</issn><eissn>1462-0332</eissn><abstract>We aimed to assess SSc mortality by age in the general population over the past five decades.
This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters.
SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)].
Mortality for SSc has steadily decreased at younger ages over the past five decades.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>37216898</pmid><doi>10.1093/rheumatology/kead233</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6831-4538</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-0324 |
ispartof | Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.466-471 |
issn | 1462-0324 1462-0332 1462-0332 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10836968 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
subjects | Clinical Science Databases, Factual Humans Mortality Risk Factors Scleroderma, Systemic |
title | Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Steady%20decrease%20in%20systemic%20sclerosis%20mortality%20rates%20at%20younger%20ages%20over%20the%20past%20five%20decades&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Yen,%20Eric%20Y&rft.date=2024-02-01&rft.volume=63&rft.issue=2&rft.spage=466&rft.epage=471&rft.pages=466-471&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kead233&rft_dat=%3Cproquest_pubme%3E2818055205%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2818055205&rft_id=info:pmid/37216898&rfr_iscdi=true |